Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
drugs
7
×
national blog main
national top stories
texas blog main
7
×
texas top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
cancer
fda
startups
abbvie
astrazeneca
celgene
eli lilly
investing
pfizer
teva pharmaceutical
amgen
What
bio
drug
fda
medical
roundup
annual
companies
conference
drugs
make
new
week
ahead
alzheimer’s
american
announced
approval
approved
arguments
asco
ash
assessed
attention
big
biotech
biotechs
blood
borne
branded
cancers
center
center’s
choices
chose
class
close
commercialized
commissioner
communities
company
Language
Current search:
drugs
×
biotech
×
" texas blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
